Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
87 hedge funds and large institutions have $301M invested in Immunomedics Inc in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 17 closing their positions.
109% more capital invested
Capital invested by funds: $144M → $301M (+$157M)
40% more call options, than puts
Call options by funds: $2.26M | Put options by funds: $1.62M
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
5% less funds holding
Funds holding: 92 → 87 (-5)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.51M |
| 2 |
PA
Perceptive Advisors
New York
|
+$2.74M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$2.36M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.33M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.4M |
| 2 |
DM
Deerfield Management
New York
|
-$3.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.63M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$1.23M |
| 5 |
Goldman Sachs
New York
|
-$969K |
IMMU Hedge Fund Activity: Q1 2016 in Review
87 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2016, worth a combined $301M — up 109% from $144M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of IMMU and 13 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 28 added.
The largest buyer was Acuta Capital Partners, adding an estimated $3.51M. The largest seller was Fidelity Investments, cutting an estimated $4.4M.
- 87 institutional investors held Immunomedics Inc (IMMU) as of Q1 2016, down from 92 in Q4 2015.
- Funds reported $301M of Immunomedics Inc stock for Q1 2016, up 109% quarter-over-quarter.
- 13 funds opened new Immunomedics Inc positions in Q1 2016 and 17 closed out, a net change of -4 holders.
- The largest Immunomedics Inc buyer in Q1 2016 was Acuta Capital Partners, an estimated $3.51M added.
- The largest Immunomedics Inc seller in Q1 2016 was Fidelity Investments, an estimated $4.4M sold.
Based on aggregated 13F filings for Q1 2016.